Niki BioSolutions NIKI
NASDAQ NIKI
$8.58 +0.38 (+4.63%)
At close: Aug 21, 2026 · 4:00 PM EDT

Niki BioSolutions, Inc. (NIKI) Return on Capital Employed (2025)

Niki BioSolutions' (NIKI) quarterly Return on Capital Employed came in at 64.01% in Q4 2025, up 60.14% on a QoQ basis from 160.57% in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Return on Capital Employed (2025) Analysis & Trends

Niki BioSolutions (NIKI) has 1 years of Return on Capital Employed data on file, last reported at 64.01% in Q4 2025.

  • Quarterly Return on Capital Employed changed N/A year-over-year to 64.01% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 64.01% (changed N/A YoY) and the FY2025 annual result came in at 8.1%, down 377.0% from the prior year.
  • Return on Capital Employed climbed to 64.01% in Q4 2025, from 160.57% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 64.01% in Q4 2025 to a low of 160.57% in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Nov 30, 2025 -64.01%
Aug 31, 2025 -160.57%